Let’s discuss your aseptic fill-finish project.
For pharmaceutical companies, equipment suppliers and technology partners looking for independent, experience-based support in isolators, Annex 1, aseptic process design and CAPEX risk governance.
Useful first topics
Concept, URS, vendor strategy, isolator / RABS decisions, FAT/SAT readiness, CQV logic and Annex 1 alignment.
Send and Email to us.
02Connect professionally with Juergen M. Metzger.
03Services
Review advisory areas before requesting a project discussion.
Contact Pharma-Technology-Consulting, LLC
Use email for direct project inquiries or LinkedIn for a professional introduction. Please include enough context to make the first discussion productive.
Aseptic fill-finish, isolator / RABS strategy, Annex 1 readiness, CAPEX governance, market access and independent OEM / pharma advisory.
Remote strategic advisory, onsite workshops, technical reviews, concept assessments, FAT/SAT support and ongoing retainer-based guidance.
Project phase, intended timeline, product / process type, barrier concept and the main concern: compliance, CAPEX risk, vendor selection, transfer, CQV or execution.
